QUOTE AND NEWS
SeekingAlpha  Apr 24  Comment 
ResMed Inc. (RMD) F3Q2014 Results Earnings Conference Call April 23, 2014 4:30 PM ET Executives Mick Farrell - Chief Executive Officer Brett Sandercock - Chief Financial Officer Jim Hollingshead - President, Americas Robert...
The Australian  Apr 24  Comment 
MEDICAL technology group ResMed has lifted its third quarter earnings 6pc, despite flat sales from its key United States market.
newratings.com  Apr 23  Comment 
WASHINGTON (dpa-AFX) - ResMed Inc. (RMD) Wednesday reported an increase in third-quarter net earnings to $90 million or $0.63 per share from $85 million or $0.58 per share last year. Revenues for the quarter were up 4% at $397.8 million compared...
MarketWatch  Mar 25  Comment 
Quick action may be necessary to avoid 50% penalty, writes Bill Bischoff.
StreetInsider.com  Feb 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Macquarie+Upgrades+ResMed+%28RMD%29+to+Outperform/9230523.html for the full story.
SeekingAlpha  Jan 24  Comment 
ResMed Inc. (RMD) F2Q 2014 Earnings Call January 23, 2014 4:30 p.m. ET Executives Michael Farrell - Chief Executive Officer Brett Sandercock - Chief Financial Officer James Hollingshead - President of Americas Geoff Neilson -...
Sydney Morning Herald  Jan 24  Comment 
Sleep disorder equipment supplier ResMed has achieved profit growth but says its performance in the US market has been disappointing.     
The Australian  Jan 23  Comment 
MEDICAL manufacturer ResMed has posted a record H1 profit despite weaker-than-expected US sales due to increased competition.
Benzinga  Jan 23  Comment 
International Game Technology (NYSE: IGT) was down 9.07 percent to $16.05 after the company missed on the bottom line in its first quarter report. ResMed (NYSE: RMD) was down as well, falling 6.15 percent to $44.00 after the company missed on...
Sydney Morning Herald  Jan 23  Comment 
Medical device maker ResMed has brushed off disappointing sales in the United States to post a moderate rise in revenue and 12 per cent rise in net profit     




 
TOP CONTRIBUTORS

’’’ResMed’’’ (NYSE:RMD) serves the sleep disorder breathing (SDB) market by providing devices and diagnostics. Though the company maintains that there have been 3,500 peer-reviewed clinical studies on SDB, they still estimate that the US market is only 10% penetrated. Further the US market is the most penetrated market in the world. The company estimates that the sleep therapy market is $2 billion in size and can grow to be 10 times greater.

Obstructive Sleep Apnea

Obstructive sleep apnea is frequently seen among physicians. It occurs when the air pressure inside the body differs from outside the body. The soft pallet closes and the person does not get air. Physiologically, the sleeping person responds briefly as if they were being choked. Adrenaline shoots through the body and the person jerks (myoclonic jerk) just enough to create air flow. A person with chronic severe obstructive sleep apnea may simulate being choked dozens of times per night. This is not conducive to good health.

People are always somewhere on a sliding scale between 'fight or flight' and 'rest and digest'. Fight or flight is associated with adrenaline and rest and digest is associated with serotonin. When adrenaline shoots through the body the person is somewhat in two hyper states, and that can really get the body out of whack- especially if it occurs several times a night. Adrenaline mobilizes sugar and encourages the pancreas to produce insulin, which takes sugar to the big muscles needed to fight or sprint away from a fight. Currently under investigation are the effects of repeated shocks to insulin production. Some suggest that it can actually cause diabetes frequently concurrent withObesity. 80% of type two diabetics have a form of SBD. Clinical data show CPAP therapy improves blood pressure, glucose control, and insulin sensitivity.

Complex Sleep Apnea

In the Fall of 2006, the Mayo clinic published a peer-reviewed study suggesting that 15% of the patients coming through their sleep center suffered from complex sleep apnea. Further it was stated that RMDs product, VPAP Adapt SV, was far superior to the current standard of care.

RMD Devices and Screening

RMD makes a CPAP for continuous positive air pressure. This allows the air pressure inside and outside the body to be similar. There is a generator which maintains pressure, and a mask which fits over the nose and mouth. People who breathe through their noses do not need the full face mask, and RMD has a nasal only product for them.

Product developments and improvements have gone to reduce the noise made by the generator and make it lighter. The masks have also been improved to be more comfortable, better fitting, and more reliable.

The most basic functions of CPAP and other devices can be created relatively easily and there are a number of low end price competitors. RMD had not competed with them in the past, but introduced the C-Series Tango to compete in that segment.

ApneaLink screens and offers diagnosis of some SDB. It works at home where the person uses something similar to an nasal oxygen tube to collect information about the breathing and pressure patterns throughout the night. The person turns it on before going to sleep and turns it off in the morning. The data can be sent for analysis via a USB SanDisk (SNDK) through the internet.

Other Treatment and Screening

There is a surgical procedure which removes tissue in the soft pallet. The patient is awake and can hear the sounds of the cutting devices which usually create a bad smelling smoke.

Sleep centers collect information as people sleep in the laboratory. Sometime electrodes are placed on the patients head.

Recent Developments

RMD performed a voluntary recall of some 300,000 units of the S8 generator. The company was only aware of 7 generators of the 300,000 that had defects causing it to put out excess heat. The company defended its brand name costing $60 million for the recall.

Most major cardiac associations advocate SBD screening.

The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) recommends pre-operative screening. The Joint Commission likens it to the time as pulse-ox machines went from relatively unknown to a standard of care.

Competitors

Respironics (RESP) which serves other ventilation markets as well.




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki